96
Participants
Start Date
August 26, 2020
Primary Completion Date
February 9, 2024
Study Completion Date
May 23, 2024
Tildacerfont/Placebo
Tablet, administered daily
Spruce Study Site, Nedlands
Spruce Study Site, Philadelphia
Spruce Study Site, Philadelphia
Spruce Study Site, Baltimore
Spruce Study Site, Columbia
Spruce Study Site, Hickory
Spruce Study Site, West Palm Beach
Spruce Clinical Site, Tampa
Spruce Study Site, Birmingham
Spruce Clinical Site, Memphis
Spruce Study Site, Columbus
Spruce Study Site, Cleveland
Spruce Study Site, Canton
Spruce Study Site, Cincinnati
Spruce Clinical Site, Indianapolis
Spruce Clinical Site, Minneapolis
Spruce Study Site, Rochester
Spruce Study Site, Chicago
Spruce Study Site, Dallas
Spruce Clinical Site, Fort Worth
Spruce Clinical Site, Edinburg
Spruce Study Site, Austin
Spruce Study Site, Englewood
Spruce Clinical Site, Las Vegas
Spruce Study Site, Los Angeles
Spruce Clinical Site, Orange
Spruce Study Site, Sacramento
Spruce Clinical Site, Bend
Spruce Study Site, Providence
Spruce study site, Brisbane
Spruce Study Site, Elizabeth Vale
Spruce Study Site, Melbourne
Spruce Study Site, Brasília
Spruce Study Site, São Paulo
Spruce Study Site, St. John's
Spruce Study Site, London
Spruce Study Site, Aarhus
Spruce Study Site, Copenhagen
Spruce Study Site, Tallinn
Spruce Study Site, Tartu
Spruce Study Site, Munich
Spruce Study Site, Dublin
Spruce Study Site, Milan
Spruce Study Site, Napoli
Spruce Study Site, Rome
Spruce Study Site, Torino
Spruce Study Site, Riga
Spruce Study Site, Kaunas
Spruce Study Site, Nijmegen
Spruce Study Site, Krakow
Spruce Study Site, Warsaw
Spruce Study Site, Bucharest
Spruce Study Site, Seoul
Spruce Study Site, Barcelona
Spruce Study Site, Madrid
Spruce Study Site, Seville
Spruce Study Site, Tarragona
Spruce Study Site, Falun
Spruce Study Site, Stockholm
Spruce Study Site, Sankt Gallen
Spruce Study Site, Zurich
Spruce Study Site, Istanbul
Spruce Study Site, Birmingham
Spruce Study Site, Ottawa
Spruce Study Site, Sherbrooke
Lead Sponsor
Spruce Biosciences
INDUSTRY